SCIENCE AND TECHNOLOGY - RELATED PUBLICATIONS
OVERSIGHT HEARING ON THE ADMINISTRATION'S BUDGET PROPOSAL TO REPEAL SB 322 STEM
CELL RESEARCH GUIDELINES - An oversight hearing held by the Senate Committee on
Health & Human Services. Stem cell research has the potential to develop cures
and better treatments for a variety of diseases as well as chronic conditions.
They range from diabetes to Parkinson's, to spinal chord injury, to cancer and
heart disease. The Governor's budget that he released in January proposes to
repeal this legislation to require the Department of Health Services to develop
guidelines for stem cell research that will be conducted in the State of
California. (Stock #1260-S; $4.04 - includes tax s/h) (5/04)
2004 CALIFORNIA NANOTECHNOLOGY POLICY BRIEFING APPLICATIONS, IMPLICATIONS AND
RECOMMENDATIONS - Transcript of the hearing by the Joint Committee on Preparing
California for the 21st Century. Nanotechnology is the ability to work at the
atomic and molecular levels (approximately 1/100,000th the diameter of the human
hair). Nanotechnology involves the research and development of materials,
devices and systems that exhibit physical, chemical and biological properties
that are different from those found at larger scales. For more information on
this subject visit the committee's website,
http://www.senate.ca.gov/ftp/sen/committee/JOINT/CA21ST_CENTURY/_home/
(Stock #1258-S; $4.31 - includes tax s/h) (1/04)
CALIFORNIA TANDEM MASS SPECTROMETRY PILOT PROGRAM RESULTS AND FOLLOW-UP -
Hearing held by the Senate Select Committee on Genetics, Genetic Technology, and
Public Policy. Each year, more than 500,000 babies are born in the State. The
California Department of Health Services provides newborn genetic screening
services. The basic service screens for four disorders: PKU, galactosemia,
sickle cell disease, and hypothyroidism. Without early detection and treatment,
these disorders can cause physical problems, mental retardation, and even death.
In 2000, about 420 disorders were detected through the screening program. In
January 2002, the department implemented the Tandem Mass Spectrometry Pilot
Program to expand newborn screening from 4 to more than 30 disorders. The
program ended in June 2003 due to the lack of funding. The enabling legislation
by Senator Kuehl, AB 2427, required the department to submit a report to the
legislature by January 2002, on the progress of the program. The report was to
include "the costs for screening, follow-up, and treatment as compared to the
costs of morbidity averted for each condition tested for in the program." The
purpose of this hearing is to receive the program results, if available, and
give interested parties an opportunity to discuss the program. The report is
necessary before TMS will be integrated into the standard battery of newborn
genetic testing techniques currently used in California. (Stock #1254-S; $5.12
- includes tax s/h)
CALIFORNIA'S COMPULSORY STERILIZATION POLICIES, 1909 - 1979 (EUGENICIS) - This
hearing is a follow up to a lecture that was hosted by the Senate Select
Committee on Genetics, Genetic Technology & Public Policy. Dr. Paul Lombardo
gave a lecture on the American Eugenics Movement (1217-S). At its prime during
the early to mid 1900s, eugenics was practiced through immigration restriction
laws, marriage restriction, selective breeding, and sterilization, among others.
Because very few of the lawmakers, hospital superintendents, mental health
directors, or others who were involved in the sterilization laws or practices
are alive today, we're dependent upon researchers, historians, and archived
records to help tell this story. We hope to learn from this history and be
mindful of it as we consider mental health and genetics policies in the future.
Dr. Alexandra Minna Stern, a renowned eugenics scholar, gives the presentation
for this informational hearing held on July 16, 2003. (Stock #1242-S; $10.24 -
includes tax s/h) (7/03)
EUGENICS: LESSONS FROM A HISTORY HIDING IN PLAIN SIGHT - Hearing held by the
Senate Select Committee on Genetics, Genetic Technologies and Public Safety on
March 11, 2003 as part of a lecture series. The lecturer for this hearing is
Paul A. Lombardo, Ph.D., J.D. These hearings or lectures are to heighten
awareness of ethical, social, and legal issues involving cloning, newborn
genetic screening programs, DNA databanking, genetic discrimination, and genetic
testing. (Stock #1217-S; $3.23 - includes tax s/h) (3/03)
TISSUE DONATIONS: ISSUES AND OPTIONS IN OVERSIGHT, REGULATION AND CONSENT -
This report by the Senate Office of Research analyzes issues and options in
regulation, licensing and fees, informed consent and other aspects of an
industry that is saving and improving the quality of countless lives. The
report also explores in detail the complicated issues surrounding for-profit
activities and use of tissue for cosmetic purposes in a field driven by the
altruism of bereaved families, who donate tissues from deceased loved ones with
the goal of helping others. (Stock #1215-S; $3.23 - includes tax s/h) (4/03)
RECENT HACKING OF STATE EMPLOYEE RECORDS AT THE TEALE DATA CENTER -
Informational hearing by Senator Steve Peace and the Senate Privacy Committee.
What went wrong at the Teale Data Center so that the personal information of
over 200,000 state employees, including Senator Peace, as well as committee
members, are now in the hands of hackers; and more importantly than what
happened, why it happened; why did it take months to discover the hacking; why
did it take another month before state employees were informed; what steps are
being taken to prevent such circumstances from being repeated? (Stock #1175-S;
$4.58 - includes tax s/h) (6/02)
UTILIZING TECHNOLOGY IN THE CALIFORNIA DEPARTMENT OF CORRECTIONS - While
California is the birthplace of the computer chip and home of Silicon Valley,
state government's use of information technology has not kept pace with that
legacy. The CDC is such a case. The largest department in state government, it
still struggles with a pair of outmoded and mismatched information technology
systems installed two and three decades ago. In this report the Senate Advisory
Control in State Government concludes that CDC needs significant funding to
construct an information technology system capable of meeting today's needs.
(Stock #1167-S; $4.04 - includes tax s/h) (8/02)
THE IMPACT OF FEDERAL POLICY ON REALIZING THE POTENTIAL OF STEM CELL RESEARCH
(CHILDREN, DISEASE, DISABILITIES, HEALTH MEDICAL, SCIENCE, WOMEN) - This is the
first in a series of hearings by the Health and Human Services Committee on stem
cell research. The issues discussed are legislation and how we balance the
appropriate relationship between the private and public sector; how we balance
these very sensitive medical, ethical, and legal issues that we're facing in
this policy area; and how do we ensure that stem cell research moves forward and
that we pursue research in a responsible manner. (Stock #1152-S; $7.00 -
includes tax s/h) (3/02)
THE TRANSATLANTIC PARTNERSHIP AND THE SIGNIFICANCE OF THE EUROPEAN UNION TO
CALIFORNIA AND ITS ECONOMY - Hearing held on March 6, 2002 by the Senate
Committee's on Banking, Commerce & International Trade and California-European
Trade Development. Some issues discussed were: The transatlantic partnership
which has become even more important politically and strategically in the wake
of the events of September 11th; The current European Union agenda, including
the successful launch of the Euro as a legal tender currency, and its very
positive implications for California business; and The vital and expanding
relationship between the European Union and California. (Stock #1148-S; $4.85)
(3/02)
CALIFORNIA ADVISORY COMMITTEE ON HUMAN CLONING PRESENTS ITS RECOMMENDATIONS ON
CLONING & STEM CELL RESEARCH - The purpose of this hearing held by the Senate
Select Committee on Genetics, Genetic Technologies & Public Policy is to give
the Advisory Committee an opportunity to present its findings and
recommendations related to human cloning and stem cell research. Following
their presentation and a question-and-answer period, there was an opportunity
for public comments. (Stock #1149-S; $4.85 - includes tax s/h) (1/02)
EXPANDED NEWBORN SCREENING POSSIBILITIES BY SUCHETTA BHATT, JAMES BARTLEY &
GEORGE CUNNINGHAM - This hearing held on February 5, 2002 discusses the state's
newborn genetic screening program, promising research, and what opportunities
may exist for additional screenings and/or better detection of diseases such as
PKU, sickle cell disease, and many others. (Stock #1146-S; $5.93 - include tax
s/h) (2/02)
STATE OF CALIFORNIA INFORMATIONAL TECHNOLOGIES POLICIES & PRACTICES (JOINT):
SENATE BUDGET & FISCAL REVIEW #4, ASSEMBLY BUDGET #5, AND ASSEMBLY INFORMATION &
TECHNOLOGIES - An informational hearing to discuss such issues as the state's
annual expenditures for information technology, including equipment software and
personnel; what is the current information technology policy, planning and
procurement approval process; the evaluation of the state's success in using
information technology. (Stock #1115-S; $4.31 - includes s/h) (8/01)
OUTCOMES OR OUTRAGE: A GOLDEN OPPORTUNITY FOR CALIFORNIA. HOW IS CALIFORNIA
MEASURING UP? This fourth report by the Senate Advisory Commission on cost
control in State Government evaluates the current use of performance
measurements in California State Government and reviews efforts of several
states and private businesses and comments on Federal government efforts. The
Commission believes that setting targets in costs, efficiency, services, program
outcomes, and quality and them measuring the actual performance against these
targets would result in significant improvement in every aspect of the State’s
operations. It is clear that no business or government can operate successfully
without a business plan with specific performance targets that become
commitments resulting in complete accountability. At one time among states,
California was regarded as the model for public administration. This is no
longer the case. It is hoped that this report will encourage the Governor and
the Legislature to restore the State of California to the eminent position it
once held. (Stock #1078-S; $9.16 – includes tax s/h) (4/01)
DEFENSE CONVERSION, RETENTION AND SPACE FLIGHT INDUSTRIES 1999 LEGISLATION
SESSION SUMMARY – During the first half of the legislative session, the Select
Committee held two hearings. They are the Joint Strike Fighter Hearing, 4/6/99
and the Hearing on California’s Aerospace Industry, 5/18/99. Also included in
this report is the Delegation to the Pentagon, 5/5/99. (Stock #996-S; $6.73 –
includes tax s/h) (9/99)
“TRUTH AND CONSEQUENCES OF THE GENETIC REVOLUTION” -- A three-part series of
informational hearings by the Senate Select Committee on Genetics and Public
Policy to heighten awareness about the important issues of genetic research.
Study areas include bioethics, public health, rights of privacy, assisted
reproduction and preimplantation genetic diagnosis, discrimination, health care,
DNA admissibility, accrediatation standards of genetic counselors, biotechnology
and genetic education:
Human Genetic Research, 4/8/96 (stock #893-S; $4.31 -- includes tax, s/h)
(12/96) DNA on Trial, 5/9/96 (stock #894-S; $4.31 -- includes tax, s/h) (12/96)
Animal Pharm: Old MacDonald Had a Lab, 6/24/96 (stock #895-S; $4.58 -- includes
tax, s/h) (12/96)